Premium
Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children
Author(s) -
Nilsson AL.,
VaziriSani F.,
Broberg P.,
Elfaitouri A.,
Pipkorn R.,
Blomberg J.,
Ivarsson SA.,
Elding Larsson H.,
Lernmark Å.
Publication year - 2015
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.24127
Subject(s) - autoantibody , medicine , antibody , type 1 diabetes , immunology , immunoassay , virology , enterovirus , serology , autoimmunity , multiplex , immunoglobulin g , virus , human leukocyte antigen , diabetes mellitus , antigen , biology , endocrinology , bioinformatics
Exposure to Ljungan virus (LV) is implicated in the risk of autoimmune (type 1) diabetes but possible contribution by other parechoviruses is not ruled out. The aim was to compare children diagnosed with type 1 diabetes in 2005–2011 (n = 69) with healthy controls (n = 294), all from the Jämtland County in Sweden, using an exploratory suspension multiplex immunoassay for IgM and IgG against 26 peptides of LV, human parechoviruses (HPeV), Aichi virus and poliovirus in relation to a radiobinding assay (RBA) for antibodies against LV and InfluenzaA/H1N1pdm09. Islet autoantibodies and HLA‐DQ genotypes were also determined. 1) All five LV‐peptide antibodies correlated to each other ( P < 0.001) in the suspension multiplex IgM‐ and IgG‐antibody assay; 2) The LV‐VP1_31–60‐IgG correlated with insulin autoantibodies alone ( P = 0.007) and in combination with HLA‐DQ8 overall ( P = 0.022) as well as with HLA‐DQ 8/8 and 8/X subjects ( P = 0.013); 3) RBA detected LV antibodies correlated with young age at diagnosis ( P < 0.001) and with insulin autoantibodies ( P < 0.001) especially in young HLA‐DQ8 subjects ( P = 0.004); 4) LV‐peptide‐VP1_31–60‐IgG correlated to RBA LV antibodies ( P = 0.009); 5) HPeV3‐peptide‐IgM and ‐IgG showed inter‐peptide correlations ( P < 0.001) but only HPeV3‐VP1_1–30‐IgG ( P < 0.001) and VP1_95–124‐IgG ( P = 0.009) were related to RBA LV antibodies without relation to insulin autoantibody positivity ( P = 0.072 and P = 0.486, respectively). Both exploratory suspension multiplex IgG to LV‐peptide VP1_31–60 and RBA detected LV antibodies correlated with insulin autoantibodies and HLA‐DQ8 suggesting possible role in type 1 diabetes. It remains to be determined if cross‐reactivity or concomitant exposure to LV and HPeV3 contributes to the seroprevalence. J. Med. Virol. 87:1130–1140, 2015 . © 2015 Wiley Periodicals, Inc.